Skip to main content
Fig. 5 | Arthritis Research & Therapy

Fig. 5

From: Identification of novel biomarker as citrullinated inter-alpha-trypsin inhibitor heavy chain 4, specifically increased in sera with experimental and rheumatoid arthritis

Fig. 5

Autoantigenicity of citrullinated peptide 428–447 inter-alpha-trypsin inhibitor heavy chain 4 (pITIH4) in patients with rheumatoid arthritis (RA). a Antibody reactivities against native or citrullinated pITIH4 were analyzed in patients with RA (n = 60) and healthy subjects (HS) (n = 30) by enzyme-linked immunosorbent assay. Each symbol represents a single sample. Bars show the mean ± SEM; broken line represents the cutoff value. **p < 0.01. N.S. Not significant

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us